Literature DB >> 16432507

Mechanism of adenosine-induced airways obstruction in allergic guinea pigs.

Sandra Keir1, Victoria Boswell-Smith, Domenico Spina, Clive Page.   

Abstract

Inhaled adenosine induces airway obstruction in asthmatic but not healthy subjects, a phenomenon that is also observed in various animal species when they are immunised to a relevant antigen, but which does not occur in naïve animals. The purpose of this study was to investigate the mechanisms of airway responsiveness to adenosine receptor agonists in anaesthetised allergic guinea pigs. Inhaled adenosine 5'-monophosphate (AMP), the A1-selective adenosine receptor agonist N6-cyclopentyladenosine (CPA) and ovalbumin all caused airway obstruction in allergic guinea pigs, but not naïve animals, as assessed by changes in total lung resistance. In contrast, the A(2a)-selective (CGS 21680; 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxoamido adenosine) and A3-selective (IB-MECA; 1-deoxy-1-[6-[[3-iodophenyl)-methyl]amino]-9H-purin-9-yl]-N-methyl-beta-D-ribofuranuronamide) adenosine receptor agonists failed to elicit airway obstruction in passively sensitised guinea pigs. Airway obstruction induced by AMP or CPA was not inhibited by the H1 receptor antagonist, mepyramine (1 mg kg(-1)) in passively sensitised guinea-pigs. In contrast, airway obstruction to ovalbumin was significantly inhibited by this antagonist. Airway obstruction induced by AMP and CPA was significantly inhibited in sensitised animals chronically treated with capsaicin. In contrast, airway obstruction to ovalbumin was not inhibited by this treatment. Airway obstruction induced by AMP, CPA and ovalbumin was significantly inhibited following bilateral vagotomy or pharmacological treatment with atropine (2 mg kg(-1)). Airway obstruction to CPA was inhibited by the adenosine A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX: 0.1-1 mg kg(-1)). In contrast, airway obstruction to ovalbumin was not inhibited by this treatment. These observations provide evidence indicating that AMP and CPA may induce airway obstruction in sensitised guinea pigs by a mechanism unrelated to histamine release from mast cells, but is mediated via an adenosine A1-receptor-dependent mechanism. The inhibition of AMP- and CPA-induced airway obstruction by atropine, capsaicin and bilateral vagotomy suggests a neuronal-dependent mechanism with the particular involvement of capsaicin-sensitive nerves.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432507      PMCID: PMC1751508          DOI: 10.1038/sj.bjp.0706663

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Species differences in adenosine receptor-mediated bronchoconstrictor responses.

Authors:  J R Fozard; J P Hannon
Journal:  Clin Exp Allergy       Date:  2000-09       Impact factor: 5.018

2.  Selective airway responsiveness in asthma.

Authors:  B J O'Connor; S D Crowther; J F Costello; J Morley
Journal:  Trends Pharmacol Sci       Date:  1999-01       Impact factor: 14.819

3.  Role of the vagus nerves in anaphylaxis and histamine-induced bronchoconstrictions in guinea-pigs.

Authors:  J E Mills; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

4.  Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.

Authors:  M J Cushley; A E Tattersfield; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

5.  Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis.

Authors:  R Polosa; I Ciamarra; G Mangano; G Prosperini; M P Pistorio; C Vancheri; N Crimi
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

6.  The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma.

Authors:  Stephen T Holgate
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

7.  Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammation.

Authors:  Daniel Wyss; Olivier Bonneau; Alexandre Trifilieff
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

8.  Adenosine up-regulation of the mucin gene, MUC2, in asthma.

Authors:  Nancy McNamara; Marianne Gallup; Amy Khong; Anatol Sucher; Inna Maltseva; John Fahy; Carol Basbaum
Journal:  FASEB J       Date:  2004-09-02       Impact factor: 5.191

9.  Intravenous adenosine and dyspnea in humans.

Authors:  Nausherwan K Burki; Wheeler J Dale; Lu-Yuan Lee
Journal:  J Appl Physiol (1985)       Date:  2004-09-17

10.  Ascaris-induced bronchoconstriction in primates experimentally infected with Ascaris suum ova.

Authors:  I M Richards; R P Eady; D M Jackson; T S Orr; D I Pritchard; K Vendy; E Wells
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

View more
  8 in total

1.  Evidence for both adenosine A1 and A2A receptors activating single vagal sensory C-fibres in guinea pig lungs.

Authors:  Benjamas Chuaychoo; Min-Goo Lee; Marian Kollarik; Rudolf Pullmann; Bradley J Undem
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

Review 2.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 3.  Adenosine receptors and asthma.

Authors:  Constance N Wilson; Ahmed Nadeem; Domenico Spina; Rachel Brown; Clive P Page; S Jamal Mustafa
Journal:  Handb Exp Pharmacol       Date:  2009

4.  Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells.

Authors:  Xiaoyang Hua; Kelly D Chason; Bertil B Fredholm; Deepak A Deshpande; Raymond B Penn; Stephen L Tilley
Journal:  J Allergy Clin Immunol       Date:  2008-05-09       Impact factor: 10.793

5.  A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols.

Authors:  A J Lexmond; S Keir; W Terakosolphan; C P Page; B Forbes
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

Review 6.  Therapeutic applications.

Authors:  Stephen Tilley; Jon Volmer; Maryse Picher
Journal:  Subcell Biochem       Date:  2011

7.  Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.

Authors:  S Mark Duffy; Glenn Cruse; Christopher E Brightling; Peter Bradding
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

8.  Neuronal adenosine A2A receptors signal ergogenic effects of caffeine.

Authors:  Aderbal S Aguiar; Ana Elisa Speck; Paula M Canas; Rodrigo A Cunha
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.